SignalXSignalX

Humana (HUM) 8-K Current Report: March 9, 2026

Filed: March 9, 2026
Financials
Hospital & Medical Service Plans
Humana Overview

Humana (HUM) 8-K current report filed with SEC EDGAR on March 9, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 1.01: Entry into a Material Definitive Agreement
  • Item 2.03: Creation of a Direct Financial Obligation

Humana 8-K Mar 9, 2026 Event Analysis

Item 1.01 · Entry into a Material Definitive Agreement

  • • $1.0B junior subordinated notes issued at 6.625% fixed rate, maturing Sept 15, 2056 — 30-year subordinated debt with rate reset risk after 2031
  • • Post-2031 rate resets every 5 years to 5-yr Treasury + 2.891%, with 6.625% floor — limits downside but adds refinancing uncertainty
  • • Net proceeds ~$986M; proceeds earmarked for general corporate purposes including commercial paper repayment — signals near-term liquidity management priority
  • • Notes rank junior to ALL senior debt and structurally subordinated to subsidiary liabilities — higher risk position for these noteholders vs. existing creditors
  • • Company retains option to defer interest payments up to 10 consecutive years — unusual feature that signals flexibility but flags potential cash flow stress risk

Item 2.03 · Creation of a Direct Financial Obligation

  • • Humana issued subordinated notes — a debt offering with pricing and closing announced via dual press releases (Exhibits 99.1 and 99.2)
  • • Subordinated debt ranks below senior obligations in bankruptcy, meaning higher risk but typically higher yield — relevant to existing bondholders and credit watchers
  • • Full terms (size, rate, maturity) contained in attached exhibits; investors should review for leverage and interest burden impact

Other Humana 8-K Filings

8-K Mar 2, 2026

Get deeper insights on Humana

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.